L. Somma

529 total citations
10 papers, 417 citations indexed

About

L. Somma is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, L. Somma has authored 10 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Neurology. Recurrent topics in L. Somma's work include Colorectal Cancer Treatments and Studies (6 papers), Cancer Treatment and Pharmacology (5 papers) and Neuroendocrine Tumor Research Advances (2 papers). L. Somma is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Cancer Treatment and Pharmacology (5 papers) and Neuroendocrine Tumor Research Advances (2 papers). L. Somma collaborates with scholars based in Italy and United Kingdom. L. Somma's co-authors include Emilio Bajetta, Carlo Carnaghi, Maria Di Bartolomeo, Roberto Buzzoni, Luigi Mariani, Nicoletta Zilembo, Angelo Di Leo, Corrado Gallo Stampino, Vittorio Gebbia and M. Visini and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

L. Somma

10 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Somma Italy	8	370	260	207	45	38	10	417
Antonio Cassata Italy	7	256 0.7×	97 0.4×	65 0.3×	63 1.4×	25 0.7×	12	316
Federica de Cicco Italy	10	169 0.5×	128 0.5×	70 0.3×	18 0.4×	29 0.8×	10	256
A Dirlewanger Germany	3	235 0.6×	274 1.1×	158 0.8×	8 0.2×	60 1.6×	5	302
Xu-Bao Liu China	11	256 0.7×	215 0.8×	113 0.5×	20 0.4×	67 1.8×	30	297
Amir Mearadji Netherlands	7	103 0.3×	77 0.3×	60 0.3×	32 0.7×	41 1.1×	8	164
Agnieszka Stefańska Poland	9	272 0.7×	326 1.3×	195 0.9×	9 0.2×	54 1.4×	24	370
Ronny Ben-Avi Israel	9	100 0.3×	45 0.2×	42 0.2×	116 2.6×	43 1.1×	15	267
Pablo Mójica United States	7	290 0.8×	32 0.1×	15 0.1×	77 1.7×	97 2.6×	8	397
Maria Cattoni Italy	12	91 0.2×	68 0.3×	41 0.2×	154 3.4×	63 1.7×	31	359

Countries citing papers authored by L. Somma

Since Specialization

Citations

This map shows the geographic impact of L. Somma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Somma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Somma more than expected).

Fields of papers citing papers by L. Somma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Somma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Somma. The network helps show where L. Somma may publish in the future.

Co-authorship network of co-authors of L. Somma

This figure shows the co-authorship network connecting the top 25 collaborators of L. Somma. A scholar is included among the top collaborators of L. Somma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Somma. L. Somma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Dalu, Davide, V. Filipazzi, Anna Gambaro, et al.. (2019). ABCB1 c.3435C>T polymorphism is associated with platinum toxicity: a preliminary study. Cancer Chemotherapy and Pharmacology. 83(4). 803–808. 11 indexed citations

Bajetta, Emilio, Maria Di Bartolomeo, L. Somma, et al.. (1997). Doxifluridine in colorectal cancer patients resistant to 5-fluorouracil (5-FU) containing regimens. European Journal of Cancer. 33(4). 687–690. 12 indexed citations

Bartolomeo, Maria Di, Emilio Bajetta, L. Somma, et al.. (1996). Doxifluridine as Palliative Treatment in Advanced Gastric and Pancreatic Cancer Patients. Oncology. 53(1). 54–57. 13 indexed citations

Bartolomeo, Maria Di, Emilio Bajetta, Roberto Buzzoni, et al.. (1996). Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors: A study by the Italian Trials in Medical Oncology group. Cancer. 77(2). 402–408. 233 indexed citations

Bajetta, Emilio, Maria Di Bartolomeo, L. Somma, et al.. (1996). Randomized phase II noncomparative trial of oral and intravenous doxifluridine plus levo-leucovorin in untreated patients with advanced colorectal carcinoma. Cancer. 78(10). 2087–2093. 10 indexed citations

Bajetta, Emilio, Carlo Carnaghi, L. Somma, & Corrado Gallo Stampino. (1996). A Pilot Safety Study of Capecitabine, A New Oral Fluoropyrimidine, in Patients with Advanced Neoplastic Disease. Tumori Journal. 82(5). 450–452. 28 indexed citations

Bajetta, Emilio, Marco Colleoni, Maria Di Bartolomeo, et al.. (1995). Doxifluridine and leucovorin: an oral treatment combination in advanced colorectal cancer.. Journal of Clinical Oncology. 13(10). 2613–2619. 37 indexed citations

Bartolomeo, Maria Di, Emilio Bajetta, Anna Maria Bochicchio, et al.. (1995). A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group. Annals of Oncology. 6(1). 77–79. 69 indexed citations

Bartolomeo, Maria Di, Emilio Bajetta, L. Somma, & Roberto Buzzoni. (1995). Doxifluridine: an active agent in advanced gastrointestinal cancer.. PubMed. 81(3 Suppl). 147–50. 3 indexed citations

10.

Bartolomeo, Maria Di, L. Somma, Emilio Bajetta, et al.. (1995). 719 Doxifluridine in advanced colorectal carcinoma. Parallel multicentre randomized phase II trial. European Journal of Cancer. 31. S150–S150. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact